Intestinal, Liver and Endothelial Nanoparticle Toxicity Development and evaluation of a novel tool for high-throughput data generation.
The InLiveTox project will form an interdisciplinary consortium at the European level, together with a key American research group to develop an improved in vitro model for the study of nanoparticle (NP) uptake, transport and cellular interaction, thus advancing our understanding of NP toxicity. Rather than repeat what has, or is being done in the field of aerosol NP and lung toxicology, InLiveTox will focus.
See more:
Short name and number:
InLiveTox (228625)
Name of US Partner:
UNIVERSITY OF ROCHESTER
Contact:
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT
Participating Countries:
Switzerland
Area:
Nanosciences, nanotechnologies, materials and new production technologies
Category:
FP7 Project with U.S. partner
